AWAU
NBIX icon

Alliance Wealth Advisors (Utah)’s Neurocrine Biosciences NBIX Stock Holding History

Alliance Wealth Advisors (Utah)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+1,315
New +$195K 0.04% 223
2023
Q2 		– Sell
-2,770
Closed -$280K – 234
2023
Q1 		$280K Sell
2,770
-90
-3% -$9.37K 0.11% 183
2022
Q4 		$342K Buy
+2,860
New +$335K 0.15% 147

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Alliance Wealth Advisors (Utah)'s NBIX Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 1,315 shares worth $222K. The stake represents 0.04% of the portfolio and ranks #223 among its holdings. This is a return to the name: Alliance Wealth Advisors (Utah) previously reported a position in NBIX as recently as Q1 2023.

Alliance Wealth Advisors (Utah) first reported a position in NBIX in Q4 2022 and has held it in 3 quarters since. The position peaked at $342K in Q4 2022. 154 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Alliance Wealth Advisors (Utah) held 1,315 shares of Neurocrine Biosciences worth $222K as of Q2 2026.
  • Neurocrine Biosciences was a new Alliance Wealth Advisors (Utah) position in Q2 2026.
  • Neurocrine Biosciences made up 0.04% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #223 holding.
  • Alliance Wealth Advisors (Utah) first reported a position in Neurocrine Biosciences in Q4 2022 and has held it in 3 quarters since.
  • Alliance Wealth Advisors (Utah)'s Neurocrine Biosciences position peaked at $342K in Q4 2022.
  • 154 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.